Carcinogenesis in mouse and human cells: Parallels and paradoxes

Carcinogenesis

Volumn 21, Issue 3, 2000, Pages 371-377

  Balmain, Allan ^b   Harris, Curtis C ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DNA; PROTEIN P53;

CANCER SUSCEPTIBILITY; CARCINOGEN DNA INTERACTION; CARCINOGENESIS; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; DNA ADDUCT; DNA REPAIR; GENETIC PREDISPOSITION; HUMAN; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0034109921     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.3.371     Document Type: Review

References (99)

1. Boveri, T. (1914) Zur Frage der Erstehung Maligner Tumoren. Gustav Fischer, Jena.
2. Balmain, A., Kemp, C.J., Burns, P.A., Stoler, A.B., Fowlis, D.J., and Akhurst, R.J. (1992) Functional loss of tumour suppressor genes in multistage chemical carcinogenesis. In Harris, C.C., Hirohashi, S., Ito, N., Pitot, H.C., Sugimura, T., Terada, M. and Yokota, J. (eds) Multistage Carcinogenesis. Japan Scientific Society Press, Tokyo/CRC Press, Boca Raton, FL, pp. 97-108.
3. Yuspa, S.H. (1994) The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis (33rd G.W.A. Clowes Memorial Award Lecture). Cancer Res., 54, 1178-1189.
4. Dragan, Y.P. and Pitot, H.C. (1992) Multistage hepatocarcinogenesis in the rat: insights into risk estimation. Prog. Clin. Biol. Res., 374, 261-279.
5. Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
6. Balmain, A. and Brown, K. (1988) Oncogene activation in chemical carcinogenesis. Adv. Cancer Res., 51, 147-182.
7. Bos, J.L. (1988) The ras gene family and human carcinogenesis. Mutat. Res., 195, 255-271.
8. Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
9. Kakiuchi, H., Watanabe, M., Ushijima, T., Toyota, M., Imai, K., Weisburger, J.H., Sugimura, T. and Nagao, M. (1995) Specific 5′-GGGA-3′→5′-GGA-3′ mutation of the Ape gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc. Natl Acad. Sci. USA, 92, 910-914.
10. Su, L.-K., Kinzler, K.W., Vogelstein, B., Preisinger, A.C., Moser, A.R., Luongo, C., Gould, K.A. and Dove, W.F. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670.
11. Dashwood, R.H., Suzui, M., Nakagama, H., Sugimura, T. and Nagao, M. (1998) High frequency of beta-catenin (ctnnbl) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res., 58, 1127-1129.
12. Bianchi, A.B., Fischer, S.M., Robles, A.I., Rinchik, E.M. and Conti, C.J. (1993) Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene, 8, 1127-1133.
13. Aldaz, C.M., Trono, D., Larcher, F., Slaga, T.J. and Conti, C.J. (1989) Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol. Carcinog., 2, 22-26.
14. Bianchi, A.B., Aldaz, C.M. and Conti, C.J. (1990) Non-random duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumours. Proc. Natl Acad. Sci. USA, 87, 6902-6906.
15. Bremner, R. and Balmain, A. (1990) Genetic changes in skin tumour progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell, 61, 407-417.
16. Wiseman, R.W., Cochran, C., Dietrich, W., Lander, E.S. and Soderkvist, P. (1994) Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc. Natl Acad. Sci. USA, 91, 3759-3763.
17. Burns, P.A., Kemp, C.J., Gannon, J.V., Lane, D.P., Bremner, R. and Balmain, A. (1991) Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice. Oncogene, 6, 2363-2369.
18. Ruggeri, B., DiRado, M., Zhang, S.Y., Bauer, B., Goodrow, T. and Klein-Szanto, A.J. (1993) Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl Acad. Sci. USA, 90, 1013-1017.
19. Ohgaki, H., Hard, G.C., Hirota, N., Maekawa, A., Takahashi, M. and Kleihues, P. (1992) Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds. Cancer Res., 52, 2995-2998.
20. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
21. Kemp, C.J., Fee, F. and Balmain, A. (1993) Allelotype analysis of mouse skin tumours using polymorphic microsatellites: sequential genetic alterations on chromosomes 6, 7 and 11. Cancer Res., 53, 6022-6027.
22. NK4A-beta in mouse lung tumor cells. Oncogene, 13, 1885-1891.
23. INK4b genes in 2′,3′-dideoxycytidine-and 1.3-butadiene-induced murine lymphomas. Oncogene, 16, 803-808.
24. INK4b in undifferentiated mouse skin tumors. Cancer Res., 55, 5168-5172.
25. Cairns, P., Mao, L., Merlo, A., Lee, D.J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J.E. and Sidransky, D. (1994) Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-417.
26. Kamb, A., Gruis, N.A., Weaver Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day, R.S.III, Johnson, B.E. and Skolnick, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
27. Holliday, R. (1996) Neoplastic transformation: the contrasting stability of human and mouse cells. Cancer Surv., 28, 103-115.
28. Newbold, R.F. (1997) Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found. Symp., 211, 177-189.
29. Blackburn, E.H. (1991) Structure and function of telomeres. Nature, 350, 569-573.
30. Meyerson, M., Counter, C.M., Eaton, E.N., Ellisen, L.W., Steiner, P., Caddle, S.D., Ziaugra, L., Beijersbergen, R.L., Davidoff, M.J., Liu, Q., Bacchetti, S., Haber, D.A. and Weinberg, R.A. (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90, 785-795.
31. Nakamura, T.M., Morin, G.B., Chapman, K.B., Weinrich, S.L., Andrews, W.H., Lingner, J., Harley, C.B. and Cech, T.R. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science, 277, 955-959.
32. Newbold, R.F. (1997) Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found. Symp., 211, 177-189.
33. Greenberg, R.A., Allsopp, R.C., Chin, L., Morin, G.B. and DePinho, R.A. (1998) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene, 16, 1723-1730.
34. Greenberg, R.A., Chin, L., Femino, A., Lee, K.H., Gottlieb, G.J., Singer, R.H., Greider, C.W. and DePinho, R.A. (1999) Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell, 97, 515-525.
35. Rudolph, K.L., Chang, S., Lee, H.W., Blasco, M., Gottlieb, G.J., Greider, C. and DePinho, R.A. (1999) Longevity, stress response and cancer in aging telomerase-deficient mice. Cell, 96, 701-712.
36. Chin, L., Artandi, S.E., Shen, Q., Tam, A., Lee, S.L., Gottlieb, G.J., Greider, C.W. and DePinho, R.A. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97, 527-538.
37. Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W. and Weinberg, R.A. (1999) Creation of human tumour cells with defined genetic elements. Nature, 400, 464-468.
38. Colgin, L.M. and Reddel, R.R. (1999) Telomere maintenance mechanisms and cellular immortalization. Curr. Opin. Genet. Dev., 9, 97-103. [Published erratum appears in Curr. Opin. Genet. Dev., (1999), 9, 247.]
39. Kipling, D. and Cooke, H.J. (1990) Hypervariable ultra-long telomeres in mice. Nature, 347, 400-402.
40. Coviello-McLaughlin, G.M. and Prowse, K.R. (1997) Telomere length regulation during postnatal development and ageing in Mus spretus. Nucleic Acids Res., 25, 3051-3058.
41. Nagase, H., Bryson, S., Cordell, H., Kemp, C.J., Fee, F. and Balmain, A. (1995) Distinct genetic loci control development of benign and malignant skin tumours in mice. Nature Genet., 10, 424-429.
42. Manenti, G., Falvella, F.S., Gariboldi, M., Dragani, T.A. and Pierotti, M.A. (1995) Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2. Genomics, 29, 438-444.
43. Greenberg, R.A., Chin, L., Femino, A., Lee, K.H., Gottlieb, G.J., Singer, R.H., Greider, C.W. and DePinho, R.A. (1999) Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell, 97, 515-525.
44. Zhu, J., Wang, H., Bishop, J.M. and Blackburn, E.H. (1999) Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl Acad. Sci. USA, 96, 3723-3728.
45. Balmain, A. and Pragnell, I.B. (1983) Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature, 303, 72-74.
46. Balmain, A., Ramsden, M., Bowden, G.T. and Smith, J. (1984) Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature, 307, 658-660.
47. Sukumar, S., Notari, V., Martin-Zanca, D. and Barbacid, M. (1983) Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-l locus by single point mutations. Nature, 306, 658-661.
48. Zarbl, H., Sukumar, S., Arthur, A.V., Martin-Zanca, D. and Barbacid, M. (1985) Direct mutagenesis of Ha-ras-l oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature, 315, 382-385.
49. Quintanilla, M., Brown, K., Ramsden, M. and Balmain, A. (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature, 322, 78-80.
50. Bizub, D., Wood, A.W. and Skalka, A.M. (1986) Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc. Natl Acad. Sci. USA, 83, 6048-6052.
51. Brown, K., Buchmann, A. and Balmain, A. (1990) Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumour progression. Proc. Natl Acad. Sci. USA, 87, 538-542.
52. Cheng, S.C., Prakash, A.S., Pigott, M.A., Hilton, B.D., Lee, H., Harvey, R.G. and Dipple, A. (1988) A metabolite of the carcinogen 7,12-dimethylbenz(a)anthracene that reacts predominantly with adenine residues in DNA. Carcinogenesis, 9, 1721-1723.
53. Dipple, A., Pigott, M., Moschel, R.C. and Costantino, N. (1983) Evidence that binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Cancer Res., 43, 4132-4135.
54. Gorelick, N.J., Andrews, J.L., Gu, M. and Glickman, B.W. (1995) Mutational spectra in the lacl gene in skin from 7,12-dimethylbenz[a]anthracene-treated and untreated transgenic mice. Mol. Carcinog., 14, 53-62.
55. Ross, J.A. and Nesnow, S. (1999) Polycyclic aromatic hydrocarbons: correlations between DNA adducts and ras oncogene mutations. Mutat. Res., 424, 155-166.
56. Sills, R.C., Hong, H.L., Melnick, R.L., Boorman, G.A. and Devereux, T.R. (1999) High frequency of codon 61 K-ras A→T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1.3-butadiene) for 2 years and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis, 20, 657-662.
57. Wang, X., Suzuki, T., Itoh, T., Honma, M., Nishikawa, A., Furukawa, F., Takahashi, M., Hayashi, M., Kato, T. and Sofuni, T. (1998) Specific mutational spectrum of dimethylnitrosamine in the lacl transgene of Big Blue C57BL/6 mice. Mutagenesis, 13, 625-630.
58. de Boer, J. and Hoeijmakers, J.H.J. (2000) Nucleotide excision repair and human syndromes. Carcinogenesis, 21, 453-460.
59. Ziegler, A., Leffell, D.J., Kunala, S., Sharma, H.W., Gailani, M., Simon, J.A., Halperins, A.J., Baden, H.P., Shapiro, P.E., Bale, A.E. and Brash, D.E. (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc. Natl Acad. Sci. USA, 90, 4216-4220.
60. Dumaz, N., van Kranen, H.J., de Vries, A., Berg, R.J., Wester, P.W., Van Kreijl, C.F., Sarasin, A., Daya-Grosjean, L. and de Gruijl, F.R. (1997) The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcinogenesis, 18, 897-904.
61. Jiang, W., Ananthaswamy, H.N., Muller, H.K. and Kripke, M.L. (1999) p53 protects against skin cancer induction by UV-B radiation. Oncogene, 18, 4247-4253.
62. Ruggeri, B., Caamano, J., Goodrow, T., DiRado, M., Bianchi, A., Trono, D., Conti, C.J. and Klein-Szanto, A.J.P. (1991) Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res., 51, 6615-6621.
63. Bartsch et al. (1999) Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis, 20, 2209-2218.
64. Sugimura, T. (2000) Nutrition and dietary carcinogens. Carcinogenesis, 21, 387-395.
65. Hecht, S.S. (1997) Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proc. Soc. Exp. Biol. Med., 216, 181-191.
66. 6-methylguanine built into a unique site in a viral genome. Proc. Natl Acad. Sci. USA, 81, 6271-6275.
67. Robertson, K.D. and Jones, P.A. (2000) DNA methylation: past, present and future directions. Carcinogenesis, 21, 461-467.
68. Perera, F.P. and Weinstein, I.B. (2000) Molecular epidemiology: recent advances and future directions. Carcinogenesis, 21, 517-524.
69. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
70. Hussain, S.P. and Harris, C.C. (1998) Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res., 58, 4023-4037.
71. Hill, A.B. (1965) The environment and disease: association or causation? Proc. R. Soc. Med., 58, 295-300.
72. Bennett, W.P., Hussain, S.P., Vahakangas, K.H., Khan, M.A., Shields, P.G. and Harris, C.C. (1999) Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J. Pathol., 187, 8-18.
73. Nakazawa, H., English, D., Randell, P.L., Nakazawa, K., Martel, N., Armstrong, B.K. and Yamasaki, H. (1994) UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc. Natl Acad. Sci. USA, 91, 360-364.
74. Ziegler, A., Jonason, A.S., Leffell, D.J., Simon, J.A., Sharma, H.W., Kimmelman, J., Remington, L., Jacks, T. and Brash, D.E. (1994) Sunburn and p53 in the onset of skin cancer. Nature, 372, 773-776.
75. Hussain, S.P. and Harris, C.C. (1999) Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutat. Res., in press.
76. Hussain, S.P. and Harris, C.C. (1999) p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat. Res. 428, 23-32.
77. Nelson, M.A., Futscher, B.W., Kinsella, T., Wymer, J. and Bowden, G.T. (1992) Detection of mutant Ha-ras genes in chemically initiated mous skin epidermis before the development of benign tumours. Proc. Natl Acad. Sci. USA, 89, 6398-6402.
78. Moser, A.R., Dove, W.F., Roth, K.A. and Gordon, J.I. (1992) The min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifer system. J. Cell. Biol., 116, 1517-1526.
79. Morin, P.J., Sparks, A.B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, K.W. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science, 275, 1787-1790.
80. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E. and Polakis, P. (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science, 275, 1790-1792.
81. Gat, U., DasGupta, R., Degenstein, L. and Fuchs, E. (1998) De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell, 95, 605-614.
82. Chan, E.F., Gat, U., McNiff, J.M. and Fuchs, E. (1999) A common human skin tumour is caused by activating mutations in beta-catenin. Nature Genet., 21, 410-413.
83. Brash, D.E. (1997) Sunlight and the onset of skin cancer. Trends Genet., 13, 410-414.
84. Jonason, A.S., Kunala, S., Price, G.J., Restifo, R.J., Spinelli, H.M., Persing, J.A., Leffell, D.J., Tarone, R.E. and Brash, D.E. (1996) Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl Acad. Sci. USA, 93, 14025-14029.
85. Kemp, C.J., Donehower, L.A., Bradley, A. and Balmain, A. (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell, 74, 813-822.
86. Greenhalgh,D.A., Wang, X.J., Donehower, L.A. and Roop, D.R. (1996) Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha. Cancer Res., 56, 4413-4423.
87. Wang, X.J., Greenhalgh, D.A., Jiang, A., He, D., Zhong, L., Medina, D., Brinkley, B.R. and Roop, D.R. (1998) Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis. Oncogene, 17, 35-45.
88. Brown, K., Strathdee, D., Bryson, S., Lambie, W. and Balmain, A. (1998) The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr. Biol., 8, 516-524.
89. Cornall, R.J., Aitman, T.J., Hearne, C.M. and Todd, J.A. (1991) The generation of a library of PCR-analyzed microsatellite variants for genetic mapping of the mouse genome. Genomics, 10, 874-881.
90. Dietrich, W., Hillary, K., Lincoln, S.E., Shin, H.S., Friedman, J., Dracopoli, N.C. and Lander, E.S. (1992) A genetic map of the mouse suitable for typing intraspecific crosses. Genetics, 131, 423-447.
91. Demant, P. (1992) Genetic resolution of susceptibility to cancer-new perspectives. Semin. Cancer Biol., 3, 159-166.
92. Dragani, T.A., Manenti, G. and Pierotti, M.A. (1995) Genetics of murine lung tumors. In Vande Woude, G.F. and Klein, G. (eds) Advances in Cancer Research. Academic Press. San Diego, CA, pp. 83-112.
93. Balmain, A. and Nagase, H. (1998) Cancer resistance genes in mice: models for the study ot tumour modifiers. Trends Genet., 14, 139-144.
94. Tanksley, SD. (1993) Mapping polygenes. Annu. Rev. Genet., 27, 205-233.
95. Wright, S. (1980) Genetic and organismic selection. Evolution, 34, 825-843.
96. Fijneman, R.J., de Vries, S.S., Jansen, R.C. and Demant, P. (1996) Complex interactions of new quantitative trait loci. Sluc1, Sluc2, Sluc3 and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nature Genet., 14, 465-467.
97. van Wezel, T., Stassen, A.P., Moen, C.J., Hart, A.A., van der Valk, M.A. and Demant, P. (1996) Gene interaction and single gene effects in colon tumour susceptibility in mice. Nature Genet., 14, 468-470.
98. Fijneman, R., Jansen, R., van der Valk, M. and Demant, P. (1998) High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14. Cancer Res., 58, 4794-4798.
99. Clarke, A.R. (2000) Manipulating the germline: its impact on the study of carcinogenesis. Carcinogenesis, 21, 435-441.